To include your compound in the COVID-19 Resource Center, submit it here.

FDA approves MEDI's FluMist

The FDA granted marketing approval to MedImmune (MEDI) for its

Read the full 108 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE